Literature DB >> 2392914

Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes.

J Villumsen1, A Alm.   

Abstract

Ocular hypotensive effects and side effects of two different topically applied prostaglandin (PG) esters were evaluated in a double masked study in 12 healthy males. Three doses of 15-propionat-PGF2 alpha-isopropylester (15-prop-PGF2 alpha-IE), two doses of PGF2 alpha-isopropylester (PGF2 alpha-IE), and placebo were compared. At equipotent doses 15-prop-PGF2 alpha-IE caused similar ocular side effects as PGF2 alpha-IE. It is concluded that both PGF2 alpha-IE and 15-prop-PGF2 alpha-IE reduce the IOP in normal eyes, but the use of a diester such as 15-prop-PGF2 alpha-IE does not provide a better separation between effect on IOP and side effects than PGF2 alpha-IE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2392914     DOI: 10.1111/j.1755-3768.1990.tb01935.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

Review 1.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

2.  Latanoprost--a promising new glaucoma drug.

Authors:  S Nagasubramanian
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

Review 3.  Prostaglandin analogues in the treatment of glaucoma.

Authors:  C Lindén; A Alm
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

4.  Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure.

Authors:  A H Rulo; E L Greve; P F Hoyng
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.